Three-dimensional multivoxel proton MR spectroscopy of the brain in children with neurofibromatosis type 1

American Journal of Neuroradiology

Volumn 20, Issue 7, 1999, Pages 1333-1341

  Gonen, Oded ^a   Wang, Zhiyue J ^b   Viswanathan, A Kasi ^a   Molloy, Patricia T ^b   Zimmerman, Robert A ^b  

^a FOX CHASE CANCER CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE; CREATINE; N ACETYLASPARTIC ACID;

ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; NEUROFIBROMATOSIS; PROTON NUCLEAR MAGNETIC RESONANCE; SIGNAL NOISE RATIO;

ASPARTIC ACID; BRAIN; BRAIN CHEMISTRY; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; CHOLINE; CREATINE; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; NEUROFIBROMATOSIS 1;

EID: 0032786625     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Riccardi VM. Von-Recklinghausen neurofibromatosis. N Engl J Med 1981;305:1617-1627
2. Pont MS, Elster AD. Lesions of skin and brain: modern imaging of the neurocutaneous syndromes. AJR Am J Roentgenol 1992;158:1193-1203
3. North K, Joy P, Yulle D, et al. Specific learning disabilities in children with neurofibromatosis type 1: significance of MRI abnormalities. Neurology 1994;44:878-883
4. Moore BDI, Slopis JM, Schomer D, Jackson EF, Levy BM. Neuropsychological significance of areas of high signal intensity on brain MRIs of children with neurofibromatosis. Neurology 1996;46:1660-1668
5. Joy P, Roberts C, North K, deSilva M Neuropsychological function and MRI abnormalities in neurofibromatosis type 1. Dev Med Child Neurol 1995;9:368-377
6. Castillo M, Green C, Kwock L, et al. Proton MR spectroscopy in patients with neurofibromatosis type 1: evaluation of hamartomas and clinical correlation. AJNR Am J Neuroradiol 1995;16:141-147
7. Molloy PT, Bilaniuk LT, Vaughan SN, et al. Brainstem tumors in patients with neurofibromatosis type 1: a distinct clinical entity. Neurology 1995;45:1897-1902
8. Castillo M, Kwock L, Green C, Schiro S, Wilson JD, Greenwood R. Proton MR spectroscopy in a possible enhancing hamartoma in a patient with neurofibromatosis type 1. AJNR Am J Neuroradiol 1995;16:993-996
9. DiPaolo DP, Zimmerman RA, Rorke LB, Zachai EH, Bilaniuk LT, Yachnis AT. Neurofibromatosis type 1: pathologic substrate of high intensity foci in the brain. Radiology 1995;195:721-724
10. Daston MM, Scrable H, Nordlund M, Sturbaum AK, Nissen LM, Ratner N. The protein product of the neurofibromatosis type 1 gene is expressed at highest abundance in neurons, schwann cells and oligodendrocytes. Neuron 1992;8:415-428
11. Moonen CTW, Sobering G, van Zijl PCM, Gillen J, von Kienlin M, Bizzi A. Proton spectroscopic imaging of human brain. J Magn Reson 1992;98:556-575
12. 1H MR spectra and spectroscopic imaging data. J Comput Assist Tomogr 1993; 17:191-199
13. Posse S, Schuknecht B, Smith ME, van Zijl PCM, Herschkowitz N, Moonen CTW. Short echo time proton MR spectroscopic imaging. J Comput Assist Tomogr 1993;17:1-14
14. Duyn JH, Moonen CTW. Fast proton spectroscopic imaging of human brain using multiple spin echoes. Magn Reson Med 1993;30:409-414
15. Duyn JH, Gillen J, Sobering G, van Zijl PCM, Moonen CTW. Multisection proton MR spectroscopic imaging of the brain. Radiology 1993;188:277-282
16. 1H spectroscopic imaging of human brain. Magn Reson Imaging 1992;10:315-319
17. 1H spectroscopy of human brain using a hybrid of 1D-Hadamard with 2D-chemical shift imaging. Magn Reson Med 1997;37:644-650
18. 1H chemical shift imaging reveals loss of brain tumor choline signal after administration of Gd-contrast. Magn Reson Med 1997;37:222-225
19. Gonen O, Hu J, Stoyanova R, Goelman G, Leigh JS, Brown TR. Hybrid three dimensional (1D-Hadamard, 2D-chemical shift imaging) phosphorus localized spectroscopy of a human brain. Magn Reson Med 1995;33:300-308
20. Gonen O, Murdoch JB, Stoyanova R, Goelman G. 3D multivoxel proton spectroscopy of human brain using a hybrid of 8th-order Hadamard encoding with 2D-chemical shift imaging. Magn Reson Med 1998;38:34-40
21. Dreher W, Leibfritz D. Double-echo multislice proton spectroscopic imaging using Hadamard slice encoding. Magn Reson Med 1994;31:596-600
22. Bottomley PA. Spatial localization in NMR spectroscopy in vivo. Ann N Y Acad Sci 1987;508:333-348
23. 31P) two dimensional chemical shift imaging of in vivo human brain. Magn Reson Med 1994;32:104-109
24. Maudsley AA, Matson GB, Hugg JW, Weiner MW. Reduced phase encoding in spectroscopic imaging. Magn Reson Med 1994;31:645-651
25. 1H NMR chemical shift selective (CHESS) imaging. Phys Med Biol 1985;30:341-344
26. Gonen O, Mohebbi A, Stoyanova R, Brown TR. In vivo phosphorus polarization transfer and decoupling from protons in 3D localized NMR spectroscopy of human brain. Magn Reson Med 1997;37:301-306
27. Toft PB, Christiansen P, Pryds O, Lou HC, Henriksen O. T1, T2 and concentrations of brain metabolites in neonates and adolescents estimated with H-1 MR spectroscopy. J Magn Reson Imaging 1994;4:1-5
28. Negendank W. Studies of human tumors by MRS: a review. NMR Biomed 1992;5:303-324
29. Ott D, Henning J, Ernst T. Human brain tumors: assessment with in vivo proton MR spectroscopy. Radiology 1993;186:745-752
30. 1H MRS in vivo in brain tumors: experience of Siemens cooperative clinical trial. Anticancer Res 1996;16:1533-1538
31. Preul MC, Caramanos Z, Collins DL, et al. Accurate, noninvasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy. Nat Med 1996;2:323-326
32. Hagberg G, Burlina AP, Mader I, Roser W, Radue EW, Seelig J. In vivo proton MR spectroscopy of human gliomas: definition of metabolic coordinates from multidimensional classification. Magn Reson Med 1995;34:242-252
33. Sutton LN, Wang ZJ, Gusnard D, et al. Proton magnetic resonance spectroscopy of pediatric brain tumors. Neurosurgery 1992;31:195-202
34. Tzika AA, Vigneron DB, Ball WS, Dunn RS, Kirks DR. Localized proton MR spectroscopy of the brain in children. J Magn Reson Imaging 1993;3:719-729